International Journal of Molecular Sciences· 2018Q1· Review
Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery
- 1,227citations
- Q1SCImago
- 2018year
Short summary
Innovative technologies like AI, organ-on-chip, and computational molecular design are accelerating natural product-based drug discovery, enabling faster evaluation of safety, pharmacokinetics, and efficacy for complex diseases.
AI-generated from the title and abstract; the full text is not read.
Key points
- Modern drug discovery requires evaluating safety, pharmacokinetics, and efficacy, which can be challenging with isolated natural compounds.
- New technologies like Artificial Intelligence, organ-on-chip, and microfluidics are automating and speeding up drug discovery.
- Computational molecular design and predictive software are crucial for identifying molecular targets and predicting drug development features.
- These innovations enable novel drug design and synthesis based on natural compounds, improving the efficiency of drug development.
AI-generated from the title and abstract; the full text is not read.
Abstract
The therapeutic properties of plants have been recognised since time immemorial. Many pathological conditions have been treated using plant-derived medicines. These medicines are used as concoctions or concentrated plant extracts without isolation of active compounds. Modern medicine however, requires the isolation and purification of one or two active compounds. There are however a lot of global health challenges with diseases such as cancer, degenerative diseases, HIV/AIDS and diabetes, of which modern medicine is struggling to provide cures. Many times the isolation of "active compound" has made the compound ineffective. Drug discovery is a multidimensional problem requiring several parameters of both natural and synthetic compounds such as safety, pharmacokinetics and efficacy to be evaluated during drug candidate selection. The advent of latest technologies that enhance drug design hypotheses such as Artificial Intelligence, the use of 'organ-on chip' and microfluidics technologies, means that automation has become part of drug discovery. This has resulted in increased speed in drug discovery and evaluation of the safety, pharmacokinetics and efficacy of candidate compounds whilst allowing novel ways of drug design and synthesis based on natural compounds. Recent advances in analytical and computational techniques have opened new avenues to process complex natural products and to use their structures to derive new and innovative drugs. Indeed, we are in the era of computational molecular design, as applied to natural products. Predictive computational softwares have contributed to the discovery of molecular targets of natural products and their derivatives. In future the use of quantum computing, computational softwares and databases in modelling molecular interactions and predicting features and parameters needed for drug development, such as pharmacokinetic and pharmacodynamics, will result in few false positive leads in drug development. This review discusses plant-based natural product drug discovery and how innovative technologies play a role in next-generation drug discovery.
The authors' abstract, as published at the source. International Journal of Molecular Sciences, 2018 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Pharmacology (Medicine)
PharmacologyMedicine